Rhodes Jason P

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Apr 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.2M
Net Open-Market Flow
-$4.2M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 28, 2026Sell(S)60K$18.38$1.1M1.6M
Apr 28, 2026Sell(S)119K$18.38$2.2M4.9M
Apr 28, 2026Sell(S)1K$18.38$22K9K
Apr 28, 2026Sell(S)47K$18.38$865K1.2M
Apr 28, 2026Sell(S)26$19.00$4941.6M
Apr 28, 2026Sell(S)52$19.00$9884.9M
Apr 28, 2026Sell(S)1$19.00$199K
Apr 28, 2026Sell(S)21$19.00$3991.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001577014-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: